Drug Profile
Staphylococcus aureus type 336 vaccine - Nabi
Alternative Names: S. aureus type 336 vaccine - NabiLatest Information Update: 20 Jan 2011
Price :
$50
*
At a glance
- Originator Nabi Biopharmaceuticals
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 20 Jan 2011 Discontinued - Phase-I/II for Staphylococcal infections in USA (Parenteral)
- 04 Dec 2008 Phase-I/II clinical trials in Staphylococcal infections in USA (Parenteral)
- 07 Jun 2007 Suspended - Phase-I for Staphylococcal infections in USA (unspecified route)